Related Experiment Video
Updated: May 20, 2026
03:20
Measuring Constipation in a Drosophila Model of Parkinson's Disease
Published on: September 22, 2023
[Gastrointestinal dysfunction in idiopathic Parkinson's disease].
1AG Klinische Neuroanatomie (Abteilung Neurologie), Zentrum Klinischer Forschung, Universität Ulm, Ulm, Deutschland.
Der Nervenarzt
|June 30, 2012
Summary
Gastrointestinal dysfunction, including constipation and swallowing difficulties, is common in Parkinson's disease and can precede diagnosis. These symptoms impact quality of life and medication effectiveness, highlighting the need for better management strategies.
Area of Science:
- Neurology
- Gastroenterology
Context:
- Gastrointestinal (GI) dysfunction is a prevalent non-motor symptom in Parkinson's disease (PD), affecting patients throughout all disease stages.
- Symptoms range from sialorrhea and dysphagia to delayed gastric emptying and constipation, often appearing in the premotor phase as prodromal markers.
Purpose:
- To explore the pathophysiology of GI dysfunction in Parkinson's disease, focusing on synucleinopathy in the enteric nervous system (ENS) and vagus nerve.
- To discuss the diagnostic approaches and current therapeutic limitations for GI motility disorders in PD.
Summary:
- Parkinson's disease involves synucleinopathy affecting the dorsal motor nucleus of the vagus nerve and the ENS, preceding dopaminergic neurodegeneration.
- GI dysfunction impacts patient well-being and antiparkinsonian medication efficacy, notably causing motor fluctuations due to delayed gastric emptying.
- Diagnostic tools include patient history, clinical findings, esophagography, gastric scintigraphy, and colonic transit time assessment.
Impact:
- Understanding the early involvement of the GI tract in PD can lead to earlier diagnosis and intervention.
- Improved management of GI symptoms can enhance patient quality of life and optimize PD treatment.
- Further research into therapeutic options for GI dysmotility in PD is warranted, potentially involving agents like 5-HT4 agonists.
More Related Videos
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:20Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...